Overview

Adjuvant Quisinostat in High-Risk Uveal Melanoma

Status:
RECRUITING
Trial end date:
2030-05-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if giving participants quisinostat will prevent participants' uveal melanoma tumor from spreading. The researchers want to find out the effects that quisinostat has on participants' condition.
Phase:
PHASE2
Details
Lead Sponsor:
University of Miami
Collaborators:
Joseph and Florence Mandel Family Foundation
Viriom
Treatments:
quisinostat